12 Jul 2026 ⋅ 5 min read Peter Dunk

Are All Generics Really the Same? Bioequivalence, Fillers and Why a New Pack Can Feel Different

Are All Generics Really the Same? Bioequivalence, Fillers and Why a New Pack Can Feel Different

A generic costs a fraction of the brand and carries the same active ingredient, yet plenty of people swear a new pack "feels different." Sometimes that is imagination. Sometimes it is real, and the reason is written into the rules that approve generics in the first place. This guide explains what bioequivalence actually guarantees, what it leaves open, and the short list of medicines where a switch between manufacturers is worth watching.

In short

  • A generic must contain the same active ingredient at the same dose as the brand, and must prove bioequivalence: it delivers that ingredient into the blood at a comparable rate and extent.
  • Bioequivalence is a statistical test, not a claim of being identical. The accepted band means average exposure can sit a little above or below the brand and still pass.
  • The inactive ingredients, the fillers, binders, dyes and coatings, are not required to match. These can change how a tablet disintegrates, tastes or is tolerated.
  • For most medicines the difference is irrelevant. It matters for a small group of narrow therapeutic index drugs, where the effective dose and the risky dose sit close together.
  • If a new pack genuinely feels different, the cause is usually a filler or release difference, an intolerance, or coincidence, not a fake or weak product.

What does bioequivalence actually guarantee?

Bioequivalence guarantees the generic puts the same active ingredient into your bloodstream at a rate and total amount close enough to the brand that the difference is not expected to matter clinically. Regulators test this in healthy volunteers, measuring the peak blood level and the total exposure over time, then compare the generic to the reference product.

The catch is in the word "close." The standard band used by regulators such as the US Food and Drug Administration requires the 90% confidence interval for average exposure to fall inside roughly 80 to 125 percent of the brand. That sounds wide, but it describes the confidence interval of the average across many people, not the dose in your single tablet, and in practice approved generics cluster much closer to the brand than the limits suggest. It is a genuine control, not a loophole, but it is a band, not a promise of an identical number.

If the ingredient is the same, why can a pack feel different?

Because the parts that are not the active ingredient, the fillers and the coating, are not required to be the same, and they change how the tablet behaves. Two versions of the same drug can use different binders, different dyes, a different coating or a different disintegration profile. That can alter how fast the tablet breaks down, how it sits in a sensitive stomach, or whether someone reacts to a particular dye or a lactose filler.

There is also the honest human factor. Expecting a cheaper pill to work less well can produce real symptoms on its own, an effect measured again and again in blind studies. A different shape, colour or name is enough to plant that expectation. None of this means the medicine is weak or fake. It means "same active ingredient" and "identical experience" are not the same claim.

Which medicines is this worth watching for?

A short list of narrow therapeutic index drugs, where a small change in blood level can tip from too little to too much. For these, many prescribers prefer to keep a person on one consistent source rather than switching brands each refill:

  • Thyroid replacement such as levothyroxine, where dose is fine-tuned by blood test and a small shift can unbalance it.
  • Blood thinners like warfarin, some anti-epileptic drugs, and certain immunosuppressants after a transplant.

For the vast majority of everyday medicines, an antihistamine, a statin, a sildenafil or tadalafil tablet, switching manufacturers is not something you need to think about. If you take one of the narrow-window drugs above and notice a change after a new pack, that is worth raising rather than ignoring.

What should I do if my generic feels different?

Note what changed, keep taking it unless a doctor says otherwise, and raise it rather than quietly stopping. A few practical points:

  • Check whether the manufacturer actually changed. Pharmacies switch suppliers regularly, so a "different" pack is often just a different maker of the same approved generic.
  • Separate the drug from the dye. If you suspect an intolerance to a filler or colouring, that is a real thing a pharmacist can help you work around by finding another version.
  • For a narrow-window medicine, ask whether you can be kept on a single consistent source, and whether a blood test is warranted after a switch.
  • Do not double up or stop abruptly to "test" it. That introduces a bigger risk than the filler difference you are chasing.

The honest bottom line

Approved generics are held to a real, measured standard, and the active ingredient is genuinely the same medicine. What is not standardised is everything around it, and that is where the occasional real difference, and a lot of imagined ones, come from. For most drugs it is a non-issue. For a handful, consistency is worth protecting. Knowing which is which is the whole game.

This article is educational and does not replace advice from a doctor or pharmacist who knows your health history.

Sources

  1. Generic Drug Facts — US FDA
  2. Orange Book Preface (therapeutic equivalence) — US FDA
  3. Evaluation of Therapeutic Equivalence — Guidance for Industry — US FDA
Published 12 July 2026 · Updated 12 July 2026

Active ingredients